Recombinant Human Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-hVEGF) is selectively expressed in steroidogenic glands and promotes the growth of endocrine gland endothelium. The identification of tissue-selective angiogenic factors raises the possibility that other secreted molecules in this class exist. Consistent with such an expression pattern, the human EG-VEGF gene promoter has a potential binding site for steroidogenic factor-1, a pivotal element for steroidogenic-specific transcription. In the human ovary, the expression of EG-VEGF is temporally and spatially complementary to the expression of VEGF-A, both in the follicular and in the luteal phase, suggesting complementary and coordinated roles of these molecules in ovarian angiogenesis. Also, EG-VEGF expression correlates with vascularity in the polycystic ovary syndrome, a leading cause of infertility.
Note: This EG-hVEGF is fully bio-active as determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml.
- Product Reviews
- Product Publications
If you've used this product in a publication, let us know. Email email@example.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Name Catalog # Size PEDF PR27157 20 ug PEDF PR27157 5 ug VEGF PR15028 10 ug VEGF 120 PR15033 25 ug VEGF 120 PR15033 5 ug VEGF 121 PR15029 25 ug VEGF 121 PR15029 5 ug VEGF 121, CF PR15029CF 25 ug VEGF 121, CF PR15029CF 5 ug VEGF 162 PR15030 25 ug VEGF 162, CF PR15030CF 25 ug VEGF 164 PR15034 25 ug VEGF 164 PR15034 25 ug VEGF 164 PR15035 10 ug VEGF 164 PR15035 50 ug VEGF 164, CF PR15034CF 25 ug VEGF 164, CF PR15034CF 5 ug VEGF 164, CF PR15035CF 10 ug VEGF 164, CF PR15035CF 50 ug VEGF 165 PR15031 10 ug VEGF 165 PR15031 50 ug VEGF 165, CF PR15031CF 10 ug VEGF 165, CF PR15031CF 50 ug VEGF, CF PR15028CF 10 ug VEGF-C PR27170 1 mg VEGF-C PR27170 10 ug VEGF-C PR27170 2 ug VEGF/PIGF Heterodimer PR15032 5 ug VEGF/PIGF Heterodimer, CF PR15032CF 5 ug